Weight-Based Furosemide Dosing

Furosemide dosing is not strictly weight-based in adults; instead, it is titrated according to clinical indication, renal function, and diuretic response, with pediatric dosing calculated per kilogram of body weight.

Pediatric Weight-Based Dosing

Standard Pediatric Dosing

Oral or intravenous furosemide should be initiated at 0.5–2 mg/kg per dose, administered up to six times daily, with a maximum total daily dose of 10 mg/kg/day in children with severe edema or nephrotic syndrome 1.
For infants with congenital nephrotic syndrome, administer IV furosemide 0.5–2 mg/kg at the end of each albumin infusion in the absence of marked hypovolemia or hyponatremia 1.
High doses exceeding 6 mg/kg/day should not be given for periods longer than one week to avoid ototoxicity 2.
Infusions should be administered over 5–30 minutes to prevent hearing loss 2.

Pediatric Pharmacokinetic Considerations

Pediatric patients, including infants with chronic lung disease, exhibit reduced renal clearance and a prolonged elimination half-life compared with adults, leading to slower overall drug disposition while maintaining the same rapid onset (minutes IV, ~1 hour oral) 2.
In infants with different diseases and reasonably normal renal function who required administration of furosemide, a very steep log dose-response curve to a 1 mg/kg intravenous dose was found, suggesting that higher doses may not result in a significant increase in diuretic response 3.
The lowest mean furosemide urinary excretion rate and its concentration in urine associated with a significant diuresis were found to be 0.58 ± 0.33 μg/kg/min and 24.2 ± 10.5 μg/ml, respectively 3.

Pediatric Monitoring

Monitor electrolytes (particularly potassium and sodium), blood pressure, and renal function closely during furosemide therapy in children 1.
In children with acute renal failure caused by acute gastroenterocolitis or glomerulonephritis, the total daily dose of furosemide should not exceed 100 mg 3.

Adult Dosing by Clinical Indication

Acute Heart Failure and Pulmonary Edema

Initiate with a 20–40 mg IV bolus over 1–2 minutes for diuretic-naïve patients or those on low oral doses 2.
For patients with prior diuretic exposure or severe volume overload, the initial IV dose should be 40–80 mg, adjusted based on renal function 2.
The IV dose should be at least equivalent to the patient's chronic oral dose when switching from oral therapy 2.
Do not exceed 100 mg in the first 6 hours or 240 mg in the first 24 hours in acute heart failure 1, 2.
If inadequate response after 2 hours, double the dose, but never exceed 160–200 mg per individual bolus 2.
Increase the dose in 20-mg increments every 2 hours until adequate diuresis is achieved 2.

Chronic Heart Failure Maintenance

Start with 20–40 mg orally once daily as a single morning dose 1, 2.
Titrate upward based on clinical response, targeting a daily weight loss of 0.5–1.0 kg until dry weight is achieved 1, 2.
Do not exceed 160 mg/day without adding a second diuretic class (thiazide or aldosterone antagonist), as this represents the ceiling effect for monotherapy 1, 2.

Cirrhosis with Ascites

Start with oral furosemide 40 mg combined with spironolactone 100 mg as a single morning dose, maintaining a 100:40 ratio 1, 2.
Increase both drugs simultaneously every 3–5 days if weight loss and natriuresis are inadequate, maintaining the 100:40 ratio 1, 2.
Maximum furosemide dose is 160 mg/day in cirrhosis; exceeding this indicates diuretic resistance requiring large-volume paracentesis 1, 2.
Oral administration is preferred in cirrhotic patients due to good bioavailability and avoidance of acute reductions in GFR associated with IV administration 2.

Nephrotic Syndrome

Commence furosemide at 0.5–2 mg/kg per dose IV or orally up to six times daily (maximum 10 mg/kg per day) for severe edema 1, 2.
Administer IV furosemide 0.5–2 mg/kg at the end of albumin infusions in the absence of marked hypovolemia or hyponatremia 1, 2.

Dosing Adjustments for Renal Impairment

Chronic Kidney Disease (CKD)

Patients with reduced GFR often require higher doses of furosemide to achieve therapeutic tubular concentrations, not lower doses 1.
Loop diuretics remain effective and are the preferred diuretic class when creatinine clearance is <40 mL/min, unlike thiazides which lose effectiveness at this level of renal function 1.
In patients with advanced heart failure and moderate renal impairment (GFR 52 mL/min/1.73 m²), the furosemide dose should not be lowered, as these renal parameters do not mandate dose reduction 1.

Severe Renal Insufficiency

In patients with creatinine clearance less than 20 ml/min/1.73 m², the upper plateau of the dose-response curve was attained with single intravenous doses of furosemide 120–160 mg 4.
There appears to be no need to administer larger single doses than 120–160 mg in such patients, as remnant nephrons demonstrate an exaggerated response to furosemide 4.
Maximal response expressed as fractional excretion of sodium was increased approximately 60% in patients with severe renal insufficiency compared to normal subjects 4.

Acute Kidney Injury (AKI)

Furosemide should NOT be used to prevent or treat AKI itself—only to manage volume overload that complicates AKI 2.
Furosemide does not prevent AKI and may increase mortality when used for this purpose 2.
In hemodynamically stable, volume-overloaded AKI patients, furosemide may be beneficial for managing fluid balance 2.

Continuous Infusion Protocol

When to Use Continuous Infusion

Consider continuous infusion after an initial bolus in patients with volume overload who require doses exceeding 160 mg/day 2.
Continuous infusion may be more effective than intermittent boluses for overcoming diuretic resistance by providing more stable tubular drug concentrations 2.

Infusion Dosing

Start with a 40 mg IV loading dose, followed by 10–40 mg per hour (maximum infusion rate 4 mg/min) 2.
Maximum rates should not exceed 4 mg/min during administration to avoid ototoxicity 2.
Total dose limits should not exceed 100 mg in the first 6 hours and 240 mg in the first 24 hours 2.

Critical Monitoring Requirements

Hemodynamic Preconditions

Systolic blood pressure must be ≥90–100 mmHg before administering furosemide 1, 2.
Do not administer furosemide to hypotensive patients expecting hemodynamic improvement—it will worsen hypoperfusion and precipitate cardiogenic shock 2.

Electrolyte and Renal Monitoring

Check electrolytes (particularly potassium and sodium) and renal function within 6–24 hours after starting IV furosemide, then every 3–7 days during active titration 1, 2.
Monitor daily weights at the same time each day, targeting maximum loss of 0.5 kg/day without peripheral edema or 1.0 kg/day with peripheral edema 1, 2.
Place a bladder catheter to monitor urine output hourly in acute settings and rapidly assess treatment response 2.
Target urine output >0.5 mL/kg/hour as an indicator of adequate diuretic response 2.

Absolute Contraindications Requiring Immediate Cessation

Stop furosemide immediately if systolic blood pressure drops <90 mmHg, severe hyponatremia (sodium <120–125 mmol/L) develops, severe hypokalemia (<3 mmol/L) occurs, or anuria develops 1, 2.
In cirrhotic patients, also stop if worsening hepatic encephalopathy, progressive renal failure, or incapacitating muscle cramps occur 1, 2.

Managing Diuretic Resistance

Sequential Nephron Blockade

If adequate diuresis is not achieved after 24–48 hours of standard furosemide dosing, add a second diuretic class rather than escalating furosemide alone beyond 160 mg/day 1, 2.
Options include hydrochlorothiazide 25 mg PO, spironolactone 25–50 mg PO, or metolazone 2.5–5 mg PO 1, 2.
Combination therapy with thiazides or aldosterone antagonists is more effective than escalating furosemide alone 1, 2.

High-Dose Furosemide in Refractory Cases

High-dose furosemide (≥0.5 g/day) can be administered for at least four weeks in patients with severe cardiac failure refractory to lower doses and conventional therapy 5.
Mean maintenance dose of furosemide was 0.7 g/day and the maximum dose averaged 1.3 g/day, with a peak dose of 8 g/day used successfully in one patient 5.
Doses of 250 mg and above must be given by infusion over 4 hours to prevent ototoxicity 2.
High-dose furosemide is logical and effective therapy (with other measures) for severe cardiac failure and relatively safe when administered cautiously 5.

Common Pitfalls to Avoid

Do not withhold furosemide in patients with mild azotemia (creatinine rise <0.3 mg/dL) who remain symptomatic from volume overload, as continued congestion is associated with worse outcomes 1, 2.
Do not under-dose out of fear of hypotension or renal dysfunction; ongoing congestion worsens outcomes and undermines other heart-failure therapies (e.g., ACE inhibitors, β-blockers) 1.
Do not persist with 40 mg furosemide when the patient has significant fluid retention; this dose is insufficient and delays euvolemia 1.
Do not exceed 160 mg/day furosemide without adding another diuretic class, as the ceiling effect offers no additional benefit and raises adverse-event risk 1, 2.
Premature diuretic discontinuation due to excessive concern about azotemia is a dangerous error, leading to persistent volume overload and paradoxically worse outcomes 1.

Special Populations

Elderly Patients

Start with low doses (≈20 mg IV) and titrate more slowly because older adults have a 2–3-fold longer furosemide half-life, increased risk of orthostatic hypotension, and reduced renal clearance 2.
Perform frequent monitoring of supine and standing blood pressure, renal function, and serum potassium during dose adjustments 2.

Hemodialysis Patients

Hemodialysis patients who produce ≥100 mL of urine per day are appropriate candidates for initiating furosemide therapy 2.
The diuretic response to furosemide tends to decline over time as residual renal function progressively worsens 2.
Loop diuretics should be used with caution in this population because of the potential for ototoxic adverse effects 2.

Key Takeaway Algorithm

Pediatric patients: Start at 0.5–2 mg/kg per dose, up to 6 times daily, maximum 10 mg/kg/day 1, 3.
Adult acute heart failure: Start with 20–40 mg IV bolus (or equivalent to home dose), double every 2 hours if needed, maximum 160–200 mg per bolus 2.
Adult chronic heart failure: Start with 20–40 mg PO once daily, titrate to maximum 160 mg/day before adding second diuretic 1, 2.
Cirrhosis with ascites: Start with 40 mg PO + spironolactone 100 mg, maintain 100:40 ratio, maximum furosemide 160 mg/day 1, 2.
Renal impairment (CrCl <20 mL/min): Maximum single IV dose 120–160 mg; higher doses do not increase response 4.
Diuretic resistance: Add thiazide or aldosterone antagonist rather than exceeding furosemide 160 mg/day 1, 2.
Monitor: Electrolytes and renal function within 6–24 hours, then every 3–7 days; daily weights targeting 0.5–1.0 kg loss 1, 2.

What is the appropriate weight‑based dosing regimen for furosemide in children and adults, including adjustments for renal function?

Help us tailor your experience